Suppr超能文献

老年医疗保险心力衰竭住院患者30天全因再入院与长期预后的关联

Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.

作者信息

Arundel Cherinne, Lam Phillip H, Khosla Rahul, Blackman Marc R, Fonarow Gregg C, Morgan Charity, Zeng Qing, Fletcher Ross D, Butler Javed, Wu Wen-Chih, Deedwania Prakash, Love Thomas E, White Michel, Aronow Wilbert S, Anker Stefan D, Allman Richard M, Ahmed Ali

机构信息

Veterans Affairs Medical Center, Washington, DC.

Georgetown University Hospital/Washington Hospital Center, Washington, DC.

出版信息

Am J Med. 2016 Nov;129(11):1178-1184. doi: 10.1016/j.amjmed.2016.06.018. Epub 2016 Jul 9.

Abstract

BACKGROUND

Heart failure is the leading cause for 30-day all-cause readmission. We examined the impact of 30-day all-cause readmission on long-term outcomes and cost in a propensity score-matched study of hospitalized patients with heart failure.

METHODS

Of the 7578 Medicare beneficiaries discharged with a primary diagnosis of heart failure from 106 Alabama hospitals (1998-2001) and alive at 30 days after discharge, 1519 had a 30-day all-cause readmission. Using propensity scores for 30-day all-cause readmission, we assembled a matched cohort of 1516 pairs of patients with and without a 30-day all-cause readmission, balanced on 34 baseline characteristics (mean age 75 years, 56% women, 24% African American).

RESULTS

During 2-12 months of follow-up after discharge from index hospitalization, all-cause mortality occurred in 41% and 27% of matched patients with and without a 30-day all-cause readmission, respectively (hazard ratio 1.68; 95% confidence interval 1.48-1.90; P <.001). This harmful association of 30-day all-cause readmission with mortality persisted during an average follow-up of 3.1 (maximum, 8.7) years (hazard ratio 1.33; 95% confidence interval 1.22-1.45; P <.001). Patients with a 30-day all-cause readmission had higher cumulative all-cause readmission (mean, 6.9 vs 5.1; P <.001), a longer cumulative length of stay (mean, 51 vs 43 days; P <.001), and a higher cumulative cost (mean, $38,972 vs $34,025; P = .001) during 8.7 years of follow-up.

CONCLUSIONS

Among Medicare beneficiaries hospitalized for heart failure, 30-day all-cause readmission was associated with a higher risk of subsequent all-cause mortality, higher number of cumulative all-cause readmission, longer cumulative length of stay, and higher cumulative cost.

摘要

背景

心力衰竭是30天全因再入院的主要原因。我们在一项对心力衰竭住院患者进行倾向评分匹配的研究中,考察了30天全因再入院对长期预后和费用的影响。

方法

在阿拉巴马州106家医院(1998 - 2001年)以心力衰竭为主要诊断出院的7578名医疗保险受益人中,出院后30天仍存活的患者有1519人发生了30天全因再入院。利用30天全因再入院的倾向评分,我们组建了一个匹配队列,其中有1516对患者,分别为有和没有30天全因再入院的患者,在34项基线特征上达到平衡(平均年龄75岁,56%为女性,24%为非裔美国人)。

结果

在首次住院出院后的2 - 12个月随访期间,有和没有30天全因再入院的匹配患者中,全因死亡率分别为41%和27%(风险比1.68;95%置信区间1.48 - 1.90;P <.001)。在平均3.1年(最长8.7年)的随访期间,30天全因再入院与死亡率之间的这种有害关联持续存在(风险比1.33;95%置信区间1.22 - 1.45;P <.001)。在8.7年的随访期间,有30天全因再入院的患者有更高的累积全因再入院率(平均6.9次对5.1次;P <.001)、更长的累积住院时间(平均51天对43天;P <.001)以及更高的累积费用(平均38,972美元对34,025美元;P =.001)。

结论

在因心力衰竭住院的医疗保险受益人中,30天全因再入院与随后更高的全因死亡风险、更高的累积全因再入院次数、更长的累积住院时间以及更高的累积费用相关。

相似文献

1
Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.
Am J Med. 2016 Nov;129(11):1178-1184. doi: 10.1016/j.amjmed.2016.06.018. Epub 2016 Jul 9.
2
Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
Am J Med. 2016 Oct;129(10):1067-73. doi: 10.1016/j.amjmed.2016.05.008. Epub 2016 Jun 2.
3
Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure.
Circ Heart Fail. 2015 Jul;8(4):733-40. doi: 10.1161/CIRCHEARTFAILURE.115.002153. Epub 2015 May 27.
4
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
Am J Med. 2015 Jul;128(7):715-21. doi: 10.1016/j.amjmed.2014.11.036. Epub 2014 Dec 30.
6
Digoxin and 30-Day All-Cause Readmission in Long-Term Care Residents Hospitalized for Heart Failure.
J Am Med Dir Assoc. 2017 Sep 1;18(9):761-765. doi: 10.1016/j.jamda.2017.03.016. Epub 2017 May 11.
8
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.
Am J Med. 2014 Jan;127(1):61-70. doi: 10.1016/j.amjmed.2013.08.027. Epub 2013 Nov 18.
9
Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure.
PLoS One. 2017 Jan 27;12(1):e0170061. doi: 10.1371/journal.pone.0170061. eCollection 2017.
10
Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
Eur J Heart Fail. 2016 Aug;18(8):1041-50. doi: 10.1002/ejhf.540. Epub 2016 Apr 25.

引用本文的文献

1
Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure.
ESC Heart Fail. 2024 Dec;11(6):4285-4295. doi: 10.1002/ehf2.15023. Epub 2024 Aug 26.
3
Leveraging home health aides to improve outcomes in heart failure: A pilot study protocol.
Contemp Clin Trials. 2024 Aug;143:107570. doi: 10.1016/j.cct.2024.107570. Epub 2024 May 11.
5
Incidence and Risk Factors for 28 Days Hospital Readmission: A Retrospective Study from Oman.
Oman Med J. 2022 Sep 30;37(5):e423. doi: 10.5001/omj.2022.91. eCollection 2022 Sep.
6
Length of stay and readmission in older adults hospitalized for heart failure.
Arch Med Sci. 2020 Jan 8;17(4):891-899. doi: 10.5114/aoms.2019.89702. eCollection 2021.
7
Readmission following both cardiac and non-cardiac acute dyspnoea is associated with a striking risk of death.
ESC Heart Fail. 2021 Aug;8(4):2473-2484. doi: 10.1002/ehf2.13369. Epub 2021 Jun 10.
8
Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers.
Clinics (Sao Paulo). 2021 Jan 20;76:e1991. doi: 10.6061/clinics/2021/e1991. eCollection 2021.
9
Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.
Am J Med. 2021 Apr;134(4):e252-e263. doi: 10.1016/j.amjmed.2020.08.030. Epub 2020 Sep 30.
10
Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure.
Heart Fail Clin. 2020 Oct;16(4):387-407. doi: 10.1016/j.hfc.2020.05.002. Epub 2020 Jun 29.

本文引用的文献

1
2
In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization.
J Am Heart Assoc. 2014 Jul 11;3(4):e001088. doi: 10.1161/JAHA.114.001088.
3
Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction.
Circ Heart Fail. 2014 Jul;7(4):590-5. doi: 10.1161/CIRCHEARTFAILURE.113.001281. Epub 2014 May 29.
4
Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalized for heart failure.
Am J Med. 2014 Jan;127(1):61-70. doi: 10.1016/j.amjmed.2013.08.027. Epub 2013 Nov 18.
6
Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease.
Am J Med. 2013 Feb;126(2):150-61. doi: 10.1016/j.amjmed.2012.06.031.
7
Rehospitalization for heart failure: predict or prevent?
Circulation. 2012 Jul 24;126(4):501-6. doi: 10.1161/CIRCULATIONAHA.112.125435.
8
Early readmission for congestive heart failure predicts late mortality after cardiac surgery.
J Thorac Cardiovasc Surg. 2012 Sep;144(3):671-6. doi: 10.1016/j.jtcvs.2012.05.031. Epub 2012 Jun 17.
9
Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.
Am J Med. 2012 Apr;125(4):399-410. doi: 10.1016/j.amjmed.2011.10.013. Epub 2012 Feb 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验